Merck Aims To Duplicate Januvia Launch Success In 2007
This article was originally published in The Pink Sheet Daily
Executive Summary
Launches for Janumet, Arcoxia and Emend IV are keys to continuing the momentum of firm’s turnaround plan, CEO Clark says.